SUREFLAP LIMITED

06399085
Active Cambridge

Manufacture of other plastic products

86 employees website.com
Information technology, telecommunications and data Manufacture of other plastic products
S

SUREFLAP LIMITED

06399085

Manufacture of other plastic products

Founded 15 Oct 2007 Active Cambridge, England 86 employees website.com
Information technology, telecommunications and data Manufacture of other plastic products
Accounts Submitted 14 Mar 2026 Next due 31 Dec 2025 6 months overdue
Confirmation Submitted 14 Jan 2026 Next due 20 Jan 2027 7 months remaining
Net assets £-2M £26M 2024 year on year
Total assets £32M £10M 2024 year on year
Total Liabilities £34M £35M 2024 year on year
Charges 3
3 satisfied

Contact & Details

Contact

Registered Address

Ground Floor Building 2030 Cambourne Business Park Cambourne Cambridge Cambridgeshire CB23 6DW England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SUREFLAP LIMITED (06399085), an active information technology, telecommunications and data company based in Cambridge, England. Incorporated 15 Oct 2007. Manufacture of other plastic products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2024
Due by 31 Dec 2025 6 months overdue

Balance Sheet & P&L (2013–2024)

Cash in Bank

N/A

Decreased by £1.31M (-100%)

Net Assets

-£1.69M

Increased by £25.57M (+94%)

Total Liabilities

£34.06M

Decreased by £35.48M (-51%)

Turnover

£21.52M

Decreased by £9.06M (-30%)

Employees

86

Decreased by 2 (-2%)

Debt Ratio

105%

Decreased by 59 (-36%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 2 Shares £48.50m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
22 Dec 20251£6.50m£6.50m
26 Nov 20241£42.00m£42.00m

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Intervet Holding Bv
100.0%
994

Persons with Significant Control

Persons with Significant Control (1)

1 Active 6 Ceased

Merck & Co., Inc.

Unknown

Active
Notified 1 Apr 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Nicholas Hill

Ceased 23 Dec 2019

Ceased

David Charles Hallas

Ceased 11 Feb 2022

Ceased

Hilton Hess

Ceased 23 Dec 2019

Ceased

Andrew Douglas Bank

Ceased 1 Apr 2019

Ceased

Kevin David Parker

Ceased 23 Dec 2019

Ceased

Brian Winston Bolton

Ceased 16 Dec 2020

Ceased

Group Structure

Group Structure

SUREFLAP LIMITED Current Company

Charges

Charges

3 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Ground Floor Premises, 2030 Cambourne Business Park, Cambourne, Cambridge (CB23 6DW) SOUTH CAMBRIDGESHIRE
Leasehold-18 Aug 2020
Ground Floor Premises, 2030 Cambourne Business Park, Cambourne, Cambridge (CB23 6DW)
Leasehold
Added 18 Aug 2020
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
14 Mar 2026AccountsAnnual accounts made up to 31 Dec 2024
14 Jan 2026Confirmation StatementConfirmation statement made on 6 Jan 2026 with updates
22 Dec 2025CapitalAllotment of shares (GBP 994) on 22 Dec 2025
19 Aug 2025OfficersAppointment of Brian David Zielinski-Smith as director on 30 Jul 2025
30 Apr 2025OfficersTermination of Andrew Douglas Bank as director on 30 Apr 2025
14 Mar 2026 Accounts

Annual accounts made up to 31 Dec 2024

14 Jan 2026 Confirmation Statement

Confirmation statement made on 6 Jan 2026 with updates

22 Dec 2025 Capital

Allotment of shares (GBP 994) on 22 Dec 2025

19 Aug 2025 Officers

Appointment of Brian David Zielinski-Smith as director on 30 Jul 2025

30 Apr 2025 Officers

Termination of Andrew Douglas Bank as director on 30 Apr 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

3 months ago on 14 Mar 2026

Confirmation statement made on 6 Jan 2026 with updates

5 months ago on 14 Jan 2026

Allotment of shares (GBP 994) on 22 Dec 2025

5 months ago on 22 Dec 2025

Appointment of Brian David Zielinski-Smith as director on 30 Jul 2025

10 months ago on 19 Aug 2025

Termination of Andrew Douglas Bank as director on 30 Apr 2025

1 years ago on 30 Apr 2025